Why the study?
Regular insulin therapy is related to worse cardiovascular outcomes in patients with type 2 diabetes and heart failure, but the underlying mechanisms remain unclear.
Key points are not available for this paper at this time.
Population
Primary cardiac fibroblasts
Answers are grounded in this paper and cite their sources.
May warrant caution with insulin in diabetic HF; leaves open STAT3 mechanisms for targeted studies.
Regular insulin therapy is significantly related to worse cardiovascular outcomes in patients with type 2 diabetes and heart failure. However, the mechanisms of the causal relationship remain unclear. In this study, we observed the effect of insulin on cardiac structure and function and found that insulin dramatically augmented angiotensin II (Ang II)-induced cardiac dysfunction, as well as the proliferation and collagen production of primary cardiac fibroblasts. Total STAT3 expression, but not activation was stimulated by insulin; the effect of insulin on Ang II-induced fibrosis disappeared when STAT3 was blocked and could be entirely suppressed by the MEK inhibitor PD0325901. Our findings suggest a noninsulin-dependent glucose-lowering regimen for patients with type 2 diabetes (T2DM) and heart failure (HF).
No takes yet. Share an insight, caveat, or question.
Cao et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: